New research shows bariatric surgery's powerful impact on liver health, reducing fatty liver disease risk and improving ...

LiverRight™, a Cincinnati-based provider of healthcare services for the U.S. Hepatology and Fatty Liver Disease communities, ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

Fatty liver disease is usually associated with ageing and obesity. However, now it is being observed among children as well ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Akero Therapeutics (AKRO) reported 96-week data in its trial of advanced MASH patients, and there seem really significant ...

Have you been diagnosed with fatty liver disease? Here are the top 10 foods that you must avoid eating right now to control fat accumulation in liver cells.

By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

Fatty acid synthase (FASN), an enzyme that drives de novo lipogenesis, plays a relevant role in metabolic disorders such as obesity, non-alcoholic fatty liver disease (NAFLD) or type 2 diabetes.